Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes

NCT03113773 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: Proleukin
DRUG: Placebo Injection

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]